Keryx Biopharmaceuticals (KERX) Stock Climbs on Analyst Upgrade

By |February 29th, 2016|

Keryx Biopharmaceuticals (NASDAQ: KERX)

Keryx Bipharmaceuticals is having an incredible day in the market today, and for good reason. Early this morning, the company was the subject of a key analyst rating upgrade. This has caused investor excitement. Today, we’ll talk about the analyst upgrade, how the market reacted to the news, and what we […]